Johnson & Johnson
- Industrie
- Pharmaceuticals
- Bourse
- États-Unis
- Pays / Région
- USA
- Date d'introduction en bourse
- 24 septembre 1944
- Effectif
- 138 200
- Site web
- www.jnj.com
Fourchette de valorisation composite · prudent $120–$150 / raisonnable $150–$190 / optimiste $190–$230. À $265.95, Au-dessus du plafond optimiste · croissance future déjà escomptée.
À la publication $234.34 (25 mai 2026)
Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Historique
Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey, with an IPO date of September 24, 1944. The company no longer includes its consumer health business, which was separated through the Kenvue spin-off, and is now organized around two segments: Innovative Medicine and MedTech. In 2026 the company achieved its 64th consecutive year of dividend increases.
Position dans le secteur
Johnson & Johnson is a healthcare company in the Drug Manufacturers - General industry, operating worldwide with about 138,200 employees. In 2025 it reported total sales of roughly $94.2 billion, split between Innovative Medicine at about $60.4 billion and MedTech at about $33.8 billion. The company has disclosed that over 75% of its sales come from categories ranked first or second in global market share, and that it has 28 platforms each exceeding $1 billion in annual sales.
Pas encore d'analyse sur cette valeur dans votre langue.